Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kara Anasti

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|January 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.
Nature Communications|November 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 25, 2016
Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized MiceKevin Wiehe, Nathan I Nicely, Bradley Lockwood, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in miceDavid R Martinez, Alexandra Schaefer, Sophie Gobeil, et al.
Cell Reports|January 4, 2016
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding SiteTodd Bradley, Daniela Fera, Jinal Bhiman, et al.
Cell Host & Microbe|September 12, 2014
Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodiesThomas B Kepler, Hua-Xin Liao, S Munir Alam, et al.
Journal of Virology|November 24, 2012
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletionS Munir Alam, Hua-Xin Liao, Georgia D Tomaras, et al.
Science Translational Medicine|November 2, 2021
A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Sophie Gobeil, et al.
Cell|January 5, 2024
Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaquesKevin O Saunders, James Counts, Bhishem Thakur, et al.
Cell Reports|March 2, 2017
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman PrimatesKevin O Saunders, Nathan I Nicely, Kevin Wiehe, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|January 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.
Nature Communications|November 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 25, 2016
Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized MiceKevin Wiehe, Nathan I Nicely, Bradley Lockwood, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in miceDavid R Martinez, Alexandra Schaefer, Sophie Gobeil, et al.
Cell Reports|January 4, 2016
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding SiteTodd Bradley, Daniela Fera, Jinal Bhiman, et al.
Cell Host & Microbe|September 12, 2014
Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodiesThomas B Kepler, Hua-Xin Liao, S Munir Alam, et al.
Journal of Virology|November 24, 2012
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletionS Munir Alam, Hua-Xin Liao, Georgia D Tomaras, et al.
Science Translational Medicine|November 2, 2021
A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Sophie Gobeil, et al.
Cell|January 5, 2024
Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaquesKevin O Saunders, James Counts, Bhishem Thakur, et al.
Cell Reports|March 2, 2017
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman PrimatesKevin O Saunders, Nathan I Nicely, Kevin Wiehe, et al.
Pageof 4